UG Healthcare Corp. Ltd. (SG:8K7)
SGX:8K7
Want to see SG:8K7 full AI Analyst Report?
8K7 Stock Chart & Stats
S$0.10
>-S$0.01(-3.23%)
At close: 4:00 PM EST
S$0.10
>-S$0.01(-3.23%)
Day’s Range― - ―
52-Week RangeS$0.07 - S$0.11
Previous CloseN/A
Volume145.10K
Average Volume (3M)131.00K
Market Cap
S$54.90M
Enterprise ValueS$78.96M
Total Cash (Recent Filing)S$45.13M
Total Debt (Recent Filing)S$28.46M
Price to Earnings (P/E)―
Beta0.81
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding623,825,800
10 Day Avg. Volume276,890
30 Day Avg. Volume131,003
Financial Highlights & Ratios
PEG Ratio0.48
Price to Book (P/B)0.43
Price to Sales (P/S)0.47
P/FCF Ratio-8.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained 51.77% revenue growth indicates enduring demand for gloves and consumables and successful sales execution. Over 2-6 months this trend supports scale benefits, better absorption of fixed costs, and strengthens the company's negotiating position with suppliers and customers.
Vertical IntegrationOwning both manufacturing and branded distribution creates durable competitive advantages: control of supply, quality, and cost; margin capture across the value chain; and stronger customer relationships. This structure supports resilience to supply shocks and pricing pressure.
Balance Sheet StabilityA strong equity base and low leverage provide financial flexibility and a buffer against industry cyclicality. Over months, moderate debt levels reduce refinancing risk and allow management to fund working capital or capacity investments without jeopardizing solvency.
Bears Say
Margin SustainabilityNegative operating and net margins show the company struggles to convert sales into profits, implying structural cost or pricing pressure. Persistently weak margins limit internal reinvestment capacity and make long-term profit recovery dependent on sustained cost cuts or higher ASPs.
Deteriorating Cash GenerationA sharp slump in free cash flow undermines operational flexibility and the ability to self-fund capex or inventory needs. Over the medium term this increases reliance on external funding, raises liquidity risk during downturns, and constrains strategic investments and working capital management.
Return On Equity / Earnings DeclineNegative ROE and a collapse in EPS signal shareholder capital is not generating returns and that earnings are volatile or absent. This structural earnings weakness raises execution risk, limits the company's ability to build retained earnings, and pressures long-term value creation.
UG Healthcare Corp. Ltd. News
8K7 FAQ
What was UG Healthcare Corp. Ltd.’s price range in the past 12 months?
UG Healthcare Corp. Ltd. lowest share price was S$0.07 and its highest was S$0.11 in the past 12 months.
What is UG Healthcare Corp. Ltd.’s market cap?
UG Healthcare Corp. Ltd.’s market cap is S$54.90M.
When is UG Healthcare Corp. Ltd.’s upcoming earnings report date?
UG Healthcare Corp. Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 102 days.
How were UG Healthcare Corp. Ltd.’s earnings last quarter?
UG Healthcare Corp. Ltd. released its earnings results on Feb 11, 2026. The company reported -S$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.002.
Is UG Healthcare Corp. Ltd. overvalued?
According to Wall Street analysts UG Healthcare Corp. Ltd.’s price is currently Overvalued.
Does UG Healthcare Corp. Ltd. pay dividends?
UG Healthcare Corp. Ltd. pays a Notavailable dividend of S$0.003 which represents an annual dividend yield of N/A. See more information on UG Healthcare Corp. Ltd. dividends here
What is UG Healthcare Corp. Ltd.’s EPS estimate?
UG Healthcare Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does UG Healthcare Corp. Ltd. have?
UG Healthcare Corp. Ltd. has 623,825,800 shares outstanding.
What happened to UG Healthcare Corp. Ltd.’s price movement after its last earnings report?
UG Healthcare Corp. Ltd. reported an EPS of -S$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of UG Healthcare Corp. Ltd.?
Currently, no hedge funds are holding shares in SG:8K7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
UG Healthcare Corp. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.00%
12-Months-Change
Fundamentals
Return on Equity
-2.36%
Trailing 12-Months
Asset Growth
-1.01%
Trailing 12-Months
Company Description
UG Healthcare Corp. Ltd.
UG Healthcare Corp. Ltd. (8K7) is a prominent player in the healthcare sector, primarily focused on the manufacturing and distribution of medical gloves and other healthcare-related products. The company operates in various markets, providing essential products to hospitals, clinics, and healthcare providers worldwide. With a commitment to quality and innovation, UG Healthcare has established a strong reputation for its nitrile and latex gloves, catering to both the medical and industrial sectors.
Technical Analysis
Hyphens Pharma International Ltd.
―
Asiamedic Limited
―
Medtecs International Corporation Ltd.
―
Alliance Healthcare Group Ltd.
―
Medinex Ltd.
―